{"schema":"hottub-news/story/v1","story":"st_a74yghoquxrue2c3mk6a","title":"Aurobindo Pharma Enters US Dermatology Market With Launch Of ADQUEY Ointment For Atopic Dermatitis","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/aurobindo-pharma-enters-us-dermatology-market-with-launch-of-adquey-a74yghoqux","count":2,"items":[{"id":"n_s5mt7iz5nilwklxl7qxa","seq":1182132,"kind":"article","title":"Aurobindo arm Acrotech Biopharma forays into U.S. dermatology market with atopic dermatitis ointment","url":"https://www.thehindu.com/business/aurobindo-arm-acrotech-biopharma-forays-into-us-dermatology-market-with-atopic-dermatitis-ointment/article71534144.ece","published":"2026-10-01T17:03:08Z","seen":"2026-10-01T17:15:54Z","lang":"en","country":"IN","source":{"id":"kite-thehindu-com-b21b31","name":"thehindu.com","domain":"thehindu.com","outlet":{"wikidata":"Q926175","name":"The Hindu","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-thehindu-com-b21b31","topics":["business"],"entities":[{"id":"Q122233295","name":"Aurobindo","type":"org"},{"id":"Q268667","name":"atopic dermatitis","type":"other"}],"mentions":3,"story":"st_a74yghoquxrue2c3mk6a","category":"health","category_p":0.3400000035762787,"category2":"economy-business","sentiment":"neutral","tone":0.25,"political":0.05000000074505806},{"id":"n_a74yghoquxrue2c3mk6a","seq":1049124,"kind":"article","title":"Aurobindo Pharma Enters US Dermatology Market With Launch Of ADQUEY Ointment For Atopic Dermatitis","url":"https://www.freepressjournal.in/business/aurobindo-pharma-enters-us-dermatology-market-with-launch-of-adquey-ointment-for-atopic-dermatitis","summary":"Hyderabad-headquartered pharmaceutical giant Aurobindo Pharma Ltd announced that its US specialty subsidiary, Acrotech Biopharma Inc., has officially launched ADQUEY ointment across the United States. The milestone that came on Wednesday marks the Indian healthcare major’s strategic entry into the lucrative American dermatology segment. ADQUEY is a non-steroidal, topical phosphodiesterase-4 (PDE4) inhibitor specifically approved for the treatment of mild-to-moderate atopic…","published":"2026-10-01T03:45:21Z","seen":"2026-10-01T04:13:34Z","lang":"en","country":"IN","source":{"id":"kite-freepressjournal-in-e26f41","name":"freepressjournal.in","domain":"freepressjournal.in","outlet":{"wikidata":"Q7735208","name":"The Free Press Journal","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"kite-freepressjournal-in-e26f41","topics":["business","topnews"],"image":"https://media.assettype.com/freepressjournal/2026-10-01/rn6zm1qq/Aurobindo.png?w=280","mentions":2,"story":"st_a74yghoquxrue2c3mk6a","category":"economy-business","category_p":0.47999998927116394,"category2":"health","sentiment":"positive","tone":0.4099999964237213,"political":0.03999999910593033}]}